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Abstract
Lymphadenopathy is a hallmark of acute infection with Borrelia burgdorferi, a tick-borne spirochete and causative agent of
Lyme borreliosis, but the underlying causes and the functional consequences of this lymph node enlargement have not
been revealed. The present study demonstrates that extracellular, live spirochetes accumulate in the cortical areas of lymph
nodes following infection of mice with either host-adapted, or tick-borne B. burgdorferi and that they, but not inactivated
spirochetes, drive the lymphadenopathy. The ensuing lymph node response is characterized by strong, rapid extrafollicular
B cell proliferation and differentiation to plasma cells, as assessed by immunohistochemistry, flow cytometry and ELISPOT
analysis, while germinal center reactions were not consistently observed. The extrafollicular nature of this B cell response
and its strongly IgM-skewed isotype profile bear the hallmarks of a T-independent response. The induced B cell response
does appear, however, to be largely antigen-specific. Use of a cocktail of recombinant, in vivo-expressed B. burgdorferi-
antigens revealed the robust induction of borrelia-specific antibody-secreting cells by ELISPOT. Furthermore, nearly a
quarter of hybridomas generated from regional lymph nodes during acute infection showed reactivity against a small
number of recombinant Borrelia-antigens. Finally, neither the quality nor the magnitude of the B cell responses was altered
in mice lacking the Toll-like receptor adaptor molecule MyD88. Together, these findings suggest a novel evasion strategy for
B. burgdorferi: subversion of the quality of a strongly induced, potentially protective borrelia-specific antibody response via
B. burdorferi’s accumulation in lymph nodes.
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Introduction
Lyme borreliosis, caused by Borrelia burgdorferi transmitted by
Ixodes spp. ticks, is the most common arthropod-borne illness in the
US and Europe, and is increasing in prevalence and expanding in
geographic distribution in the US [1,2]. Clinical manifestations are
highly varied, including involvement of the cutaneous, cardiovas-
cular, musculoskeletal, and nervous systems [3–5]. A frequent, but
largely under-studied manifestation is massive and systemic lymph
node enlargement (lymphadenopathy), observed particularly in the
regional lymph node near the site of infection in humans, and in
experimentally-infected dogs [4,6]. The lymph node enlargement
that arises in both humans and dogs is characterized by increased
cellularity and the accumulation of large pleomorphic IgM- and
IgG-positive plasma cells [6–8]. Despite these unusual character-
istics, the lymphadenopathy of Lyme borreliosis has not been well
investigated.
Several in vitro studies have shown that culture-grown B.
burgdorferi can act as mitogens when co-cultured with human or
murine naive B cells [9–16]. Therefore, the unusual lymphade-
nopathy of Lyme borreliosis might be a manifestation of non-
specific B cell activation. Massive lymph node enlargement has
also been seen in wildtype but not TLR4 gene-targeted mice
during infection with Salmonella typhimurium [17] and others have
shown a role for TLR-independent, TNF-independent [18] or
TNF-dependent [19] involvement of mast cells in non-specific
induction of lymph node enlargement. Thus, innate immune
activation might account for the lymphadenopathy observed
during infection with B. burgdorferi.
On the other hand, there is ample evidence for the induction of
specific immune responses following B. burgdorferi infection. Both
following experimental and natural infections, B. burgdorferi-specific
IgM and IgG antibodies are induced in the serum of infected
humans [5,20–24], dogs [25], and mice [26], among other host
species. Importantly, passive transfer of immune-serum from
chronically infected wildtype or T cell-deficient mice, from
naturally infected dogs, and from human patients with chronic
Lyme disease can protect mice from a challenge infection with
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antibodies are induced during the course of infection. However,
once infection is established, the immune response is incapable of
clearing infection [26,30]. Thus, understanding the host immune
response is critical to understanding and treating Lyme borreliosis.
The present study was undertaken to identify the mechanisms
involved in the lymphadenopathy induced by infection with B.
burgdorferi and to determine the nature and specificity of the
reactive B cell response. Using a mouse model of infection with
host-adapted spirochetes that faithfully recapitulates experimental
and natural infections with ticks, we show that B. burgdorferi actively
migrates into the lymph nodes, where it causes a largely specific,
but unusual B cell response.
Materials and Methods
Mice and infections
Four to six week old female C3H/He, C57BL/6 and severe
combined immunodeficient C57BL/B6.C-Prkdc
scid (SCID) mice
were obtained from The Jackson Laboratory, Bar Harbor, ME,
and maintained at UC Davis in isolator cages under conventional
housing conditions. Breeding pairs of C57BL/6.129P2/Ola-
MyD88
tm1Aki (MyD88 2/2) mice [31] were a generous gift of
Richard Flavell (Yale University), given with kind permission from
Shizuo Akira (Osaka University). The MyD882/2 mice were
rederived and bred in the specific pathogen free barrier facility at
UC Davis, and then transferred to conventional housing prior to
experiment onset.
Mice were infected with B. burgdorferi in two ways: for tick-
borne infections, five B. burgdorferi-infected nymphal ticks (or
non-infected control ticks) were placed on the dorsal thoracic
midline of mice and allowed to attach and feed to repletion. To
generate host-adapted B. burgdorferi, SCID-mice were infected
s.c. via syringe inoculation with 10
4 B. burgdorferi spirochetes
grown to mid-log phase (day 5 of culture) in 0.1 ml of sterile
medium. For infection with host-adapted spirochetes, 3 mm
2
punch biopsies from infected SCID mice were obtained from
the hairless, ethanol-cleaned ear pinnae. Biopsies were trans-
planted subcutaneously on the lateral side of the right tarsal
joint of recipient naı ¨ve C57BL/6 mice. Ear transplants
contained a mean of 1.8610
4 spirochetes, based upon
quantitative DNA analysis [32]. Control mice were transplanted
at the same location with similar tissue from uninfected SCID
mice (sham infection).
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. All
protocols involving animals were approved by the Animal Use and
Care Committee at UC Davis (Permit Number: #15330).
Borrelia burgdorferi
A clonal strain of B. burgdorferi sensu stricto (cN40) was grown in
modified Barbour-Stoenner-Kelly (BSK II) medium [33] at 33uC
and enumerated with a Petroff-Hauser bacterial counting chamber
(Baxter Scientific, McGaw Park, IL). Heat-inactivation of B.
burgdorferi was done at 56uC for one hour followed by sonication.
Aseptically collected samples of lymph nodes, spleen, inoculation
site, and urinary bladder were taken at necropsy and cultured for 7
and 14 days in BSK II medium to assess the presence of
spirochetes under dark field microscopy.
Ticks
Uninfected larval Ixodes scapularis ticks were obtained from field-
collected adults in southern Connecticut (kindly provided by
Durland Fish, Yale University). All larvae for the experiments
described in this study were derived from a single cohort. A sample
of the cohort was confirmed to be B. burgdorferi flaB negative by
PCR. To generate infected nymphs, larvae were allowed to
engorge on C3H mice that had been infected with B. burgdorferi for
2 weeks following syringe inoculation, as described previously [34].
Following feeding and molting, cohort analysis of the infected
nymphal ticks revealed that 97% of the ticks were confirmed to be
PCR positive for B. burgdorferi flaB as previously described [34].
Histology and immunohistochemistry
Lymph nodes were fixed in neutral buffered formalin,
embedded in paraffin and sectioned at 4 mm and stained with
hematoxylin and eosin or by immunohistochemistry. Sections for
immunohistochemistry were processed at room temperature and
placed on positively charged slides, air-dried, de-paraffinazed and
re-hydrated. Endogenous peroxidase activity was eliminated by
incubation in 3% H2O2 in methanol for 20 minutes. Non-specific
binding was reduced with biotin blocking solution (Vector) for 15
minutes and Power Block (InnoGenex) for 15 minutes. Immuno-
histochemical labeling of B. burgdorferi was performed by treating
sections with 0.5 mg/ml protease type VIII (Sigma Aldrich) for 10
minutes, followed by 30 minutes incubation with 1:1000 dilution
of a polyclonal immune serum from B. burgdorferi-infected rabbits
(infected for two months following inoculation with 10
4 spir-
ochetes). Antigen detection utilized a three-step streptavidin-
horseradish peroxidase technique with the substrate DAB (Vector).
For other antigens, antigen retrieval was enhanced by microwav-
ing tissue sections for 6 minutes in citrate buffer at pH 6.0.
Sections were then incubated with antibodies to B220 (CD45R,
RA3-6B2), CD138 (281-2, BD Biosciences), or Ki-67 (NeoMar-
kers), followed by incubation with biotinylated secondary antibod-
ies (Vector), streptavidin conjugated Alexa 488 and Alexa 594
(Molecular Probes) or streptavidin-horseradish peroxidase fol-
lowed by DAB (Vector), and mounting with Prolong Antifade
(Molecular Probes).
Flow Cytometry
Live cell counts of single cell suspensions of lymph nodes were
obtained using a hemocytometer and trypan blue exclusion of
non-viable cells. Staining was performed using aliquots of
6.25610
5 cells in ‘‘staining medium’’ (buffered saline solution:
Author Summary
Acute Lyme Disease is one of the most important
emerging diseases in the US. People with acute Lyme
disease often develop swollen lymph nodes, or lymphade-
nopathy, but we do not know why this happens or what
effect it has on the course of the disease. We show here
that when mice are infected with live Borrelia burgdorferi
spirochetes (the bacteria that cause Lyme disease), live
spirochetes collect in the lymph nodes. These lymph nodes
then swell up and start producing large numbers of
antibody-producing cells. Although many of these anti-
bodies can recognize the bacteria, they apparently lack the
quality to clear the infection. We hypothesize that by
moving into the lymph node, usually a site in which strong
immune responses are induced, Borrelia evades the
immune response: it goes to the lymph nodes and tricks
the immune system into making a very strong but
inadequate response.
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0.168 M KH2PO4, 0.112 M K2HPO4, 0.336 M HEPES, 0.336 M
NaOH, containing 3.5% heat-inactivated, filtered newborn calf
serum and 1 mM EDTA) for 20 min on ice. The following
antibody-conjugates were used at previously determined optimal
concentrations: CD19-Cy5PE, CD3-APC Efluor780 (both e-
biosciences), CD4-FITC, and CD8a-Cy5.5PE (both in-house
generated) after blocking Fc receptor with anti-CD16/32 (2.4G2).
Dead cells were discriminated with a live/dead violet staining kit
(Invitrogen). Data acquisition was performed on a 13-color
FACSAria instrument (BD Biosciences) [35]. Data were analyzed
using FlowJo software (kind gift from Tree Star Inc.).
Elispot
To probe for B. burgdorferi-specific antibody-producing cells by
ELISPOT, 96-well plates (#MAHAS4510, Mixed Cellulose Ester
Membrane; Millipore) were coated with 2.5 mg/mL of four
recombinant non-lipidated B. burgdorferi N40 proteins: decorin
binding proteinA (DbpA), outer surface protein C (OspC), arthritis-
related protein (Arp), and borrelia membrane protein A (BmpA) in
PBS overnight. After blocking with PBS/4% BSA, lymph node cell
suspensions were 2-fold serially diluted in medium (RPMI 1640,
292 mg/mL L- glutamine, 100 mg/mL of penicillin and streptomy-
cin, 10% heat inactivated FCS and 0.03 M 2-ME) and cultured
overnight at 37uC with 5% CO2. Cells were lysed with water and
bindingwasrevealedbyincubationwithbiotinconjugatedanti-IgM
(Southern Biotech) or anti-IgH+L (Southern Biotech) for 2 hours in
2% BSA in PBS. This was followed by SA-HRP incubation for
1 hour (Vector Laboratories) in PBS/2% BSA and by 3-amino-9-
ethylcarbazole (Sigma-Aldrich). Plates were washed and dried and
mean spots were counted in all wells with visible spots and
calculated as mean spot numbers per input cell number.
Expression and purification of recombinant proteins
Genes encoding non-lipidated B. burgdorferi N40 proteins,
previously identified by genomic expression library analysis to
react with serum from B. burgdorferi-infected mice, as described
[36], were amplified by PCR from B.burgdorferi N40 DNA using
oligonucleotide primers based on their DNA sequences (Supple-
mental Table S1). Template DNA from the original reactive clone
was denatured at 94uC for 1 min, annealed at 55uC for 1 min, and
extended at 72uC for 1 min. This process was repeated for 30
cycles. The amplified genes were cloned in frame with the
glutathione S-transferase (GT) gene into pMX, derived from a
pGEX-2T vector (Pharmacia, Piscataway, N.J.) with a modified
polylinker. The PCR-amplified DNA sequences were confirmed
by sequence comparison with the original inserts.
E. coli DH5a cells transformed with the recombinant pMX
vectors were grown to an optical density of 0.5 at 600 nm and the
recombinant GT fusion proteins were induced with 1 mM IPTG
for 2 h. Bacteria were centrifuged at 3,310 g for 20 min, pellets
were washed with PBS and bacteria lysed with PBS/1% Triton X-
100. The mixtures were sonicated and centrifuged at 35,000 g.
Supernatants containing recombinant proteins were loaded onto
glutathione-Sepharose 4B columns (Pharmacia), 25 U of thrombin
was added to remove the GT partner, and purified proteins were
eluted after 2 h.
B. burgdorferi lysate preparation
B. burgdorferi was grown to log-phase (8–10 days), pelletted by
centrifugation, resuspended in cold PBS plus MgCl2 and
centrifuged repeatedly for 5 min at 4uC 17,500 g. Samples were
stored in aliquots at 220uC. Protein concentration was deter-
mined using Bradford assay (Bio-Rad).
Hybridoma generation
B cell hybridomas were created from enlarged lymph nodes
collected at various times after infection with host-adapted B.
burgdorferi. Three independent fusions were performed using
standard protocols. Briefly, single cell suspensions from mechan-
ically disrupted lymph nodes were fused with P3-X63Ag8.653
mouse myeloma cells (ATCC CRL-1580) using PEG 1450
(ATCC). Hybridomas were selected by incubating cells in HAT
medium. Supernatants of all wells with visible cell growths were
screened by ELISA for the presence of mouse Ig as previously
described [37]. Hybridoma lines were established from all Ig-
producers and tested further for reactivity against B. burgdorferi-
specific recombinant antigens and whole B. burgdorferi lysate. Some
hybridomas were then subcloned. The Ig heavy and light chain
isotype profiles of the lines and clones were determined using the
Mouse Immunoglobulin Cytometric Bead Array Kit, (BD
Biosciences, Cat Number 550026).
Statistical analysis
Statistical analysis was performed using the two-way ANOVA
or Student’s t-test with help of Prism 5 software (GraphPad
Software). A p-value of ,0.05 was considered statistically
significant.
Results
Mice infested with B. burgdorferi-infected ticks develop
regional and distant lymphadenopathy
Since lymphadenopathy has not been documented in labora-
tory mice following B. burgdorferi infection, we first sought to
determine if and when lymphadenopathy developed in laboratory
mice infected experimentally with B. burgdorferi via the natural
route, i.e. via tick-bite. For that, B. burgdorferi-genetically
susceptible C3H/He mice [38] , were each infested with either
5 infected nymphal ticks or with 5 uninfected nymphal ticks
(sham-infected). All ticks were placed on the dorsal cervico-
thoracic midline. However, the ticks subsequently migrated and
attached to different regions of the body, particularly the head
and neck region. The most common tick attachment sites were
the ear pinnae and face.
Axillary, brachial, lumbar and inguinal lymph nodes, among
others, were collected at various times after infection and
examined for visible signs of enlargement (not shown) and to
determine cell number counts. Lymph node enlargement was
noticed for all lymph nodes from mice exposed to B. burgdorferi
infected ticks but not uninfected ticks (Figure 1A and data not
shown). By day 14 following infestation with infected ticks, the
lymph nodes closest to the tick-attachment site (axillary and
brachial) were visibly enlarged and contained significantly
increased numbers of cells in comparison to the same lymph
nodes collected from the sham-exposed mice. Lymph nodes
more distant from the attachment site (inguinal and lumbar)
showed a slightly delayed increase in cellularity (Figure 1A).
Thus, infection of laboratory mice with tick-borne B. burgdorferi
faithfully recapitulates the lymphadenopathy observed in
naturally infected humans and dogs, and suggests a relationship
between time of lymph node enlargement and proximity to the
site of infection.
Rapid lymphadenopathy in regional lymph nodes of
mice infected with host-adapted spirochetes
To directly assess the spatio-temporal relationship between the
kinetics of the lymph node enlargement and the site of B. burgdorferi
Borrelia burgdorferi Regional Lymphadenopathy
PLoS Pathogens | www.plospathogens.org 3 May 2011 | Volume 7 | Issue 5 | e1002066Figure 1. Tick-borne infection with B. burgdorferi causes systemic lymphadenopathy in mice. C3H/HeN mice (n=30) were each exposed
to five B. burgdorferi-infected nymphal Ixodes scapularis ticks (or non-infected ticks). At indicated times after tick-attachment, groups of five mice were
necropsied and (A) cellularity of four indicated lymph nodes and (B) total antibody-forming cells (AFC) of these lymph nodes were assessed by
hemocytometer count and ELISPOT analysis, respectively. Shown are mean values 6 SD per timepoint for each lymph node type. ELISPOT analysis of
lymph nodes from sham-infected mice showed no significant induction of antibody production (data not shown).
doi:10.1371/journal.ppat.1002066.g001
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their attachment location in ways that varied significantly between
mice, precluding targeted analysis of specific lymph nodes. Direct
inoculation of mice with culture-grown B. burgdorferi, on the other
hand, introduces untoward experimental variables due to the
significant antigenic changes that B. burgdorferi undergoes as it
adapts to the vertebrate host. One example is the antibody-
response to the major outer surface protein A (OspA), which is
strongly expressed in vitro and in ticks [39], but virtually absent in
mice infected with B. burgdorferi via tick-infestation or following
transplantation of tissue from infected mice containing host-
adapted spirochetes [27]. Thus, infection via injection of culture-
grown bacteria may favor distinct immune responses that differ
from those seen after tick-infection. We therefore transplanted
punch biopsies of ear pinnae from infected SCID mice, containing
host-adapted spirochetes under the skin of the right tibiotarsus
area of congenic, naı ¨ve C57BL/6 mice. The right inguinal lymph
nodes were evaluated as the regional lymph nodes.
Infection of C57BL/6 mice with host-adapted B. burgdorferi
resulted in a rapid enlargement of their regional inguinal lymph
nodes (Figures 2A, 2B). These increases closely resembled the
lymphadenopathy observed at the site of tick-attachment following
tick-borne infection, albeit with somewhat faster kinetics
(Figure 2C), possibly due to the increased time between tick-
attachment and actual infection, and/or the time it takes for B.
burgdorferi to adapt to the host-environment prior to dissemination
[34]. Similar to tick-borne infection, infection with host-adapted
spirochetes caused a generalized lymphadenopathy, with lymph
nodes more distant from the infection-site increasing slower in cell
numbers compared to those closest to the site of infection (Table 1).
Thus, this infection model faithfully recapitulated tick-borne B.
burgdorferi-induced lymphadenopathy with the advantage that we
can consistently identify the lymph nodes draining the site of
infection. The spleen was not increased in size or cellularity
following either tick-borne infection (not shown) or following
infection with host-adapted spirochetes (Table 1).
Lymphadenopathy is caused by the presence of
extracellular B. burgdorferi in the lymph nodes
Since proximity to the infection site was correlated with an
increase in lymph node cellularity, we investigated next if and
when B. burgdorferi could be cultured from the lymph nodes. Within
24 h following infection with host-adapted spirochetes, B.
burgdorferi was cultured from the closest draining right inguinal
lymph nodes, but not any other lymph nodes (Table 1). By 48 h,
the right lumbar lymph nodes became culture-positive. The right
axillary lymph nodes yielded positive culture results two days later
and before any of the contralateral lymph nodes on the left side of
the mouse. A few days after the lymph nodes became culture-
positive (about 4–6 days), a marked increase in cellularity of the
lymph nodes was consistently observed for all lymph nodes, but
not to the degree as the most proximal regional lymph nodes
(Table 1). Once culture-positive, the lymph nodes remained so for
the 90-day study period. Culture results from the spleen did not
reveal B. burgdorferi until day 10 and then also only intermittently
thereafter (Table 1).
These data suggested that the lymphadenopathy observed
during Lyme borrreliosis is caused by a massive increase in lymph
node cellularity triggered by the accumulation of live B. burdorferi
spirochetes into the lymph nodes. Alternatively, it was possible that
the culture results were a mere reflection of the presence of B.
burgdorferi in the lymph node capsule, given that the spirochete
travels along connective tissues. In that case, the increase in lymph
node cellularity would be an indirect consequence of the infection-
induced inflammation rather than the presence of the spirochetes
in the lymph nodes. To distinguish between these possibilities,
immunohistochemistry was utilized to determine the precise tissue-
location of the spirochetes in lymph nodes of mice infected for 8
days with host-adapted B. burgdorferi. The results demonstrated the
consistent presence of B. burgdorferi spirochetes in the sub-capsular
sinus and superficial cortex of infected lymph nodes (Figures 3A,
3B). Interestingly, the spirochetes were found in the lymph nodes
extracellularly appeared intact with characteristic spiral morphol-
ogy. Together with the results from the culture experiments
(Table 1), this suggests a degree of persistence of B. burgdorferi in
lymph nodes.
Because lymphadenopathy was correlated with the presence of
viable spirochetes, we determined next if lymphadenopathy could
also be induced with inactivated spirochetes. For that, mice were
either infected directly by subcutaneous inoculation in the right
tarsal region with 10
4 viable cultured spirochetes or by the same
number of spirochetes after inactivation by sonication. Inactiva-
tion was confirmed by culture of the sonicate. Right inguinal
lymph nodes were collected at days 0, 10 and 21 days post
infection and either cultured in BSK II medium or assessed for
cellularity. At days 10 and 21 post infection, B. burgdorferi was
cultured from the right inguinal lymph node of mice infected with
live spirochetes but as expected, not from mice inoculated with
inactivated spirochetes. Importantly, increases in lymph node
cellularity were not observed in mice receiving inactivated B.
burgdorferi, but were clearly induced in mice inoculated with viable
B. burgdorferi (Figure 3C).
Since B. burgdorferi might replicate in vivo and thus the results
might reflect application of differing amounts of bacteria or
bacterial antigen between these two groups, the analysis was
repeated by giving 100-fold higher amounts of inactivated
bacteria (10
6 organisms). While the increased amount of
inactivated bacteria resulted in lymph node enlargement
compared to control mice (Figures 3C, 3D), the enlargement
was significantly less (p=0.001) than that seen with viable
Borrelia (Figure 3D). Thus, we conclude that lymphadenopathy
during B. burgdorferi infection is caused by the accumulation of
viable spirochetes in lymph nodes.
Increase in lymph node cellularity is due to massive
expansion of B cells
Next, the cause of the increase in cellularity of the lymph
nodes was investigated. Immunohistochemistry on day 10 after
infection demonstrated stark differences in lymph node
organization compared to lymph nodes from uninfected mice
(Figures 4A, 4B). Morphologically, the cortex of infected
regional lymph nodes consisted of tightly packed extrafollicular
lymphocytes and very few scattered, poorly demarcated
germinal centers without a distinct mantel zone. Indeed
follicular structures appear large l ya b s e n ti nt h e s el y m p hn o d e s
(Figures 4B, 4C). The majority of the lymphocytes in the cortex
were positively labeled by B220 and thus identified as B cells
(data not shown). The largest extrafollicular B cells were
frequently arranged in distinct clusters interpreted as antibody
forming foci. These large B cells were characterized by an open
euchromatic nucleus with marginated chromatin and a large
prominent nucleolus and moderate amounts of cytoplasm,
characteristics of plasmablasts.
To distinguish between increased trapping of migrating cells
versus expansion of cells within the regional lymph nodes, cells
were labeled for Ki-67 antigen to identify proliferating cells. The
staining demonstrated large numbers of B cells in the cortex that
were actively dividing (Figure 4D). Cells in the paracortex that
Borrelia burgdorferi Regional Lymphadenopathy
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division was restricted to the B cell population only (data not
shown). Dual fluorescent labeling of Ki-67 and B220 identified the
dividing cells as B cells (Figure 4E). The exclusive and extensive
expansion of B cells was further confirmed by flow cytometry.
Whereas the lymph nodes showed no significant increases in either
CD4 or CD8 T cells compared to lymph nodes from non-infected
mice, CD19+ B cells had expanded dramatically by day 10 of
infection with live B. burgdorferi (Figure 4G). The massive increases
in B cells were absent in mice injected with inactivated B. burgdorferi
(Figure 3E).
In addition, the medullary cords of the lymph nodes from the
infected mice showed the presen c eo fl a r g en u m b e r so fp l a s m a
cells, identified by staining withC D 1 3 8( F i g u r e4 F ) ,s u g g e s t i n ga
strong induction of antibody secretion in the affected lymph
nodes. Indeed, ELISPOT analysis on regional lymph nodes
infected for up to 60 days with B. burgdorferi showed the presence
of large numbers of antibody-forming cells (AFC), with peak
responses noted around day 10 of infection (Figure 4H).
Depending on the day of study between 1–3% of the AFC
secreted antibodies were bound to the Borrelia lysate
(Figure 4H). The strong antibody secretion within the lymph
nodes following infection with host-adapted spirochetes was in
magnitude and kinetics very similar to the induction seen
following tick-borne infection with B. burgdorferi (Figure 1B), but
w a sm u c hl a r g e rt h a ns e e na f t e ri n jection of inactivated bacteria
(Figure 3F). In summary, expansion of the lymph node cortex by
reactive B cells and extrafollicular antibody forming foci
constitutes the morphological basis of lymphadenopathy in
Lyme borreliosis.
B cell expansion and differentiation following infection
with B. burgdorferi is at least in part antigen-specific
The finding of active migration of B. burgdorferi into lymph
nodes, i.e. an organ responsible for immune response induction,
appeared counter-intuitive for an organism that aims to establish
persistent infection. Therefore, we aimed to determine next
whether B. burgdorferi might cause immune subversion in these
lymph nodes. In particular we asked whether it was inducing
massive non-specific B cell expansion and differentiation to
antibody-secreting cells at the expense of an effective Borrelia-
specific antibody response. Addressing this question is complicated
by the fact that protein expression of culture-grown spirochetes
does not fully resemble Borrelia in the host, i.e. the usefulness of
protein lysates from culture-grown bacteria is limited as a source of
antigen for ELISPOT analysis.
Initial studies were therefore conducted to identify a number of
Borrelia antigens that are expressed in the host and induce robust
antibody responses. A screen of available recombinant Borrelia-
expressed antigens by ELISPOT analysis with lymph node cells
from day 14 Borrelia-infected mice showed that lymph nodes had
measurable reactivity against all of the recombinant antigens
tested. Interestingly, DbpA had the highest level of reactivity,
while the Borrelia lysate, included as a ‘‘positive’’ control,
identified a much smaller fraction of Borrelia-reactive AFC
(Figure 5A). Further analysis showed that it was possible to pool
various Borrelia antigens for ELISPOT analysis without losing
sensitivity of reactivity against each antigen (data not shown). A
pool of four recombinant antigens, consisting of DbpA, OspC,
Arp, BmpA was used as a means of measuring the Borrelia-specific
antibody response. While it clearly underestimates the number of
Table 1. B. burgdorferi presence correlates with lymphadenopathy in mice infected with host-adapted spirochetes.
Right Inguinal Lumbar Right Axillary Left Inguinal Left Axillary Spleen
Bb* Cells
{ Bb Cells Bb Cells Bb Cells Bb Cells Bb Cells
Day 0 2 5.4 2 3.2 2 3.5 2 7.6 2 5.2 2 102
Day 1 + 4.6 2 3.8 2 3.2 2 4.1 2 3.7 2 112
Day 2 + 6.1 + 4.5 2 3.6 2 5.4 2 4.1 2 105
Day 3 + 10.2 + 4.8 2 4.6 2 5.3 2 3.1 2 133
Day 4 + 8.2 + 4.6 + 5.1 2 4.9 2 3.5 2 98
Day 5 + 6.6 + 3.7 + 6.4 + 5 2 3.2 2 123
Day 7 + 57 + 5.1 + 3.2 + 2.8 + 1.7 2 106
Day 10 + 79 + 56.2 + 46 + 19 + 25 + 95
Day 14 + 20.2 + 41.3 + 62 + 44 + 54 2 132
Day 21 + 21 + 18.8 + 14.6 + 12 + 11.4 2 121
Day 28 + 16.8 + 9.2 + 12.9 + 14.4 + 10.6 2 117
Day 60 + 11.4 + 5.7 + 6.4 + 10.1 + 8.6 + 147
Day 90 + 15.4 + 6.4 + 7.4 + 11.9 + 6.2 + 138
*Cultures on lymph nodes assessed at 1 and 2 weeks. ‘‘+’’ indicates 4/4 positive and ‘‘–’’ indicates 0/4 negative culture result for B. burgdorferi (Bb).
{Mean number of total cells (610
6) of live cells from C57BL/6 mice (n=4) counted via a hemocytometer using trypan blue exclusion. Numbers in bold indicate peak of
lymph node cellularity.
doi:10.1371/journal.ppat.1002066.t001
Figure 2. Infection with host-adapted B. burgdorferi induces lymphadenopathy near the site of infection. Lymphadenopathy of the right
inguinal lymph node of C57BL/6 mice 10 days after infection via subcutaneous transplantation of small pieces of ear from B. burgdorferi-infected (A)
or non-infected (B) congenic SCID mice into their right dorsal tarsal region. (C) Shown are mean cell numbers 6 SD of right inguinal lymph nodes
from groups of four mice per timepoint. (D) Comparison of lymph node celluarity (mean 6 SD) obtained from draining lymph nodes in (C) and from
the axillary lymph nodes of tick-infected mice as shown in Figure 1.
doi:10.1371/journal.ppat.1002066.g002
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PLoS Pathogens | www.plospathogens.org 7 May 2011 | Volume 7 | Issue 5 | e1002066Figure 3. B. burgdorferi localizes to the subcapsular sinus of lymph nodes. (A, B) Immunohistochemistry with polyclonal B. burgdorferi-
specific rabbit serum, demonstrates the presence of extracellular B. burgdorferi spirochete (arrow) in the subcapsular sinus of the right inguinal lymph
node of C57BL/6 mice infected by tissue-transplant eight days prior to analysis. (C) Shown are mean cell numbers of right inguinal lymph nodes of
C57BL/6 mice (n=2 per timepoint) either infected via injection of 10
4 culture-grown live (live) or heat-killed and sonicated B. burgdorferi in PBS. ‘‘+’’
identifies positive B. burgdorferi cultures of lymph nodes (n=2 per timepoint) from the same group of mice, ‘‘2’’ shows lack of B. burgdorferi growth
in culture. Results are from one of two independent experiments that gave similar results. (D–F) Comparison of mice infected as in (C) but injected
with 10
6 inactivated B. burgdorferi for 8 days prior to analysis (D) Total numbers of cells recovered from lymph nodes. Each symbol represents results
from one animal; horizontal bars indicate the mean for the group. (E) Data shown are total numbers CD4, CD8 T cells and CD19 B cells calculated
from total cell counts and frequencies of cell subsets as determined by flow cytometry. (F) Shown are frequencies of IgG antibody-secreting cells in
lymph nodes of mice given live or inactivated B. burgdorferi. Note data are normalized to B cell numbers. Each symbol represents the results from one
mouse; the horizontal line indicates the mean for the group.
doi:10.1371/journal.ppat.1002066.g003
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binant proteins that are expressed during infection was found to be
more sensitive than testing with Borrelia lysate.
A time course analysis of C57BL/6 mice infected for up to 90
days with host-adapted B. burgdorferi showed the robust induction
of antibody-secretion within the regional lymph nodes (Figure 5B).
The kinetics of the Borrelia-specific response was identical to that
of the total antibody responses measured at the site (compare
Figure 4H with Figure 5B). Depending on the day of analysis
between 4–13% of AFC were shown to be specific for one of the
four recombinant proteins included as antigens in the analysis.
The isotype profile of the specific response showed a broad
representation of all measured isotypes. More than half of the
antibody-secreting cells appeared to generate IgM antibodies and
IgG antibody isotypes classically associated with T-independent
responses (IgG2b and IgG3, Figure 5C). Overall, the isotype
profile of the Borrelia-specific response suggested that a consid-
erable proportion of the B cell response might be T-independent,
consistent with previous observations [29,40].
Borrelia-specific B cell responses are strongly induced in
regional lymph nodes following infection
The ELISPOT results suggested that a significant fraction of
the induced B cell response was specific and directed against B.
burgdorferi. However, given that we probed with only some of the
many other Borrelia proteins that are potentially expressed
Figure 4. B. burgdorferi-induced lymphadenopathy is caused by a massive proliferation and differentiation of lymph node B cells.
(A–C) H.E. staining of right inguinal lymph node from a C57BL/6 mouse (A) sham-infected or (B) infected by tissue-transplantation with host-adapted
spirochetes 10 days prior. (C) Close-up image of (B). Note the complete lack of follicular and extrafollicular structure. (D) Immunohistochemistry on
lymph nodes as in (B, C) reveals the presence of large numbers of Ki67+ proliferating cells in the lymph node cortex. (E) Three-color
immunofluorescence identifies the Ki67+ (red) cells as B220+ (green) B cells. Blue color indicates nuclei as stained with DAPI. (F) Large numbers
CD138+ plasma cells accumulate in the medullary cords of lymph nodes of infected mice as (in B/C) (G) Shown are mean cell numbers 6 SD from 4
C57BL/6 mice per time point of CD4, CD8 T cells and CD19+ B cells in inguinal lymph nodes before (white) and at day 10 (black) of infection. Data
were calculated from flow cytometric evaluation of live cell frequencies and total live cell counts by hemocytometer with trypan blue exclusion.
Results are from one of .3 experiments performed that gave similar results. Statistical analysis was conducted by comparing results from each cell
population using Student’s t test; n.s. not significant. (H) Shown are mean numbers of antibody-secreting cells (AFC) 6 SD for total (grey bars) and
Borrelia-lysate (black bars)-specific antibodies in inguinal lymph nodes from 4 C57BL/6 mice per timepoint at the indicated times after infection with
host-adapted B. burgdorferi. Horizontal bar indicates threshold levels of detection.
doi:10.1371/journal.ppat.1002066.g004
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PLoS Pathogens | www.plospathogens.org 9 May 2011 | Volume 7 | Issue 5 | e1002066Figure 5. Strong induction of B. burgdorferi-specific antibodies following infection. (A) Indicated recombinant B. burgdorferi antigens and
lysate were tested as coating reagents for ELISPOT to enumerate B. burgdoferi-specific antibody-secreting cells (AFC) in the inguinal lymph nodes of
C57BL/6 mice infected for 14 days with host-adapted B. burgdorferi. Shown are mean numbers of antibody-secreting cells (AFC) 6 SD from 5 mice. (B)
A pool of recombinant proteins (DbpA, OspC, Arp and BmpA) was used to determine the frequencies of B. burgdorferi-specific antibody-secreting
cells (black bars) by ELISPOT in C57BL/6 mice at indicated times after infection. Grey bars indicate the total number of IgG-AFC per lymph node. For
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specific over the non-specific response was difficult. Therefore,
another series of experiments was conducted in which hybrid-
omas were generated from the regional lymph nodes to assess the
fraction of hybridomas directed against Borrelia-specific antigens
with an expanded list of recombinant Borrelia proteins. Three
successful fusions were conducted, including one on lymph nodes
at day 8 of infection, and two on day 18. The overall results from
these three fusions were similar (Figure 6A). Initial screening of
roughly 1000 wells per fusion identified between 150–350 wells
that showed antibody-secretion. Further screening of the
antibody-secreting lines indicated that between 14–24% of the
hybridoma lines generated antibodies that could be identified to
react against an expanded list of recombinant Borrelia antigens
(DbpA, OspC, Arp, BmpA, P23, P29, P32, P61 (defined in
Supplemental Table S1) [41] and/or Borrelia lysate from
cultured spirochetes.
From these fusions, 132 hybridoma lines were cultivated. Of
these, 45 were specific for B. burgdorferi antigens. The isotype profile
of the 45 hybridoma lines matched very closely that observed by
ELISPOT on Borrelia-infected lymph nodes, indicating that the
hybridoma lines were recapitulating the responses in vivo
(Figure 6B). Furthermore, the largest fraction of the 45 Borrelia-
specific hybridomas (11/45) recognized DbpA (data not shown).
This is consistent with the initial specificity screen by ELISPOT
(Figure 5A). Given that the recombinant antigen pool was likely to
underestimate the frequencies of antigen-specific B cells/hybrid-
omas, we conclude that a sizable fraction of the massive B cell
response induced during Lyme borreliosis is specific against B.
burgdorferi.
Lymphadenopathy and B cell induction are independent
of MyD88
Non-specific mitogenic stimulation of B cells with Borrelia
lipoproteins in vitro has been reported previously [9–16]. OspA, a
surface lipoprotein that is strongly expressed by Borrelia in culture,
but down-regulated upon infection of a mammalian host, was
shown to be responsible for at least some of the mitogenic activity
[11,14]. While host-adapted spirochetes are not expected to express
significant amounts of OspA, other proteins or lipids may provide
mitogenicsignalstoB cellsinvivo.Therefore,we determinedthe role
of the adaptor protein MyD88, important in TLR and IL-1-
mediated innate signaling, in regulation of initial B cell activation
and/or the lymph node enlargement. A previous study found
impaired pathogen-clearance and alterations in the antibody-
isotype profile of serum antibodies in mice lacking MyD88 [42].
MyD882/2 mice and congenic control mice were infected with
host-adapted spirochetes for ten days. The analysis revealed no role
for MyD88 in the quality or magnitude of the lymphadenopathy.
Regional lymph nodes from MyD882/2 mice had similar cell
numbers on day 10 of infection (Figure 7A), with similar
predominance of CD19+ B cells compared to control mice
(Figure 7B). Furthermore, there was no difference in the number
of Borrelia-specific IgM or total Ig secreting cells in the lymph nodes
(Figures 7C, 7D). Thus, MyD88-dependent innate signaling is not
driving the induction of lymphadenopathy, nor the massive
activation of B cell responses associated with Lyme borreliosis.
Together with the strong antigen-specific B cell responses measured
by hybridoma generation, the results suggest that Borrelia-infection
induces a specific, albeit largely extrafollicular B cell response as a
result of the accumulation of live B. burgdorferi in lymph nodes.
Figure 6. Lymph nodes of B. burgdorferi-infected mice contain large numbers borrelia-specific B cells. Shown are the results of three
independent hybridoma fusion experiments. (A) Shown are stacked bars with the total number of antibody-secreting cells (black) and the number of
lines generating B. burgdorferi-specific antibody as assessed by ELISA with four recombinant B. Burgdorferi antigens. Cells for the fusion were from
indicated lymph nodes and times after infection with host-adapted spirochetes. (B) Indicated are the Ig-isotype distribution among all B. burgdorferi-
specific hybridoma lines generated.
doi:10.1371/journal.ppat.1002066.g006
each timepoint two infected mice and two sham-infected control mice were analyzed. Shown are the mean numbers B. burgdorferi-specific antibody-
secreting cells 6 SD assessed for the individual mice from which cell spots seen in sham-infected mice were subtracted. SD was calculated from
titration curves of 3 replicates for each of the two mice analyzed. (C) Shown are the mean frequencies 6 SD of B. burgdorferi-specific antibody-
secreting cells expressing the indicated Ig-isoytypes or total Ig (black) on days 8 and 14 after infection. Data are from 4 mice per group and timepoint.
doi:10.1371/journal.ppat.1002066.g005
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This study provides new insights into the pathogenesis of
lymphadenopathy during the early stages of human Lyme
borreliosis. The results demonstrate for the first time the
extracellular accumulation of B. burgdorferi in the cortical regions
of lymph nodes and implicate the direct association of migrating B.
burgdorferi spirochetes with a marked and specific but unusual B cell
response in the lymph nodes, but not the spleens, of mice infected
with tick-borne or host-adapted spirochetes. The strong accumu-
lation of proliferating B cells in the cortical areas of the lymph
nodes, in the absence of a simultaneous accumulation of CD4 T
cells (Figures 3, 4), the lack of strongly demarcated lymph node
follicles and germinal centers in the lymph nodes (Figures 4B, 4C),
and the strongly IgM and IgG3/2b-driven specific antibody
response (Figures 5, 6) indicate that this pathogen drives the
borrelia-specific B cell response towards T cell-independence.
From these results we hypothesize that these effects of B. burgdorferi
on the Borrelia-specific B cell response constitute a novel immune-
evasion strategy.
The active migration of B. burgdorferi into sites of immune
induction appears counter-intuitive for an organism that aims to
establish persistence. Their presence in the lymph nodes and the
strong responses their presence evokes thus indicate the intricate
balance this pathogen achieves between immune induction and
immune evasion. The nature of the observed B cell response is
clearly distinct from that observed following acute infections with
other non-persistent pathogens, or following immunizations with
various protein antigens that induce mainly T cell-dependent
extrafollicular and germinal center responses [43,44]. In particular
we note a lack of clearly demarcated follicles, with it an apparent
lack of germinal centers and the accumulation of proliferating B
cells in the follicles. The presence of T-independent B cell
responses to B. burgdorferi had previously been indicated by
measurements of strong antibody-responses in the serum of T
cell-deficient mice [29]. While we cannot fully exclude the
possibility that it is the nature of the expressed Borrelia-antigens
that drive the B cell response towards its extrafolicular nature
(Figure 4C) and apparent T-independence, we believe that this
cannot fully explain our observations. A major component of the B
cell response induced to infection with host-adapted spirochetes
was directed against decorin-binding protein (DbpA) (Figures 5, 6).
When administered in adjuvant, a strong germinal center-response
was observed in the draining lymph nodes and DbpA-specific
antibody responses were strongly induced against this protein,
suggesting that this major B. burgdorferi immunogen is capable of
inducing T-dependent responses in the right context (unpubl.
observations). Furthermore, immunization with DbpA does induce
protective antibody responses [36].
Also, the strongly B cell-driven lymphadenopathy seen following
B. burgdorferi infection was not observed following immunization of
mice with culture-grown heat-killed and sonicated spirochetes
(Figures 3C, 3E), although such immunization increased both
lymph node size (Figure 3D) and induced moderate frequencies of
B. burgdorferi-specific antibody-secreting cells (Figure 3F). Thus,
either live infection and/or the presence of live extracellular
bacteria and bacterial proteins in the cortex areas of the lymph
nodes appear to trigger this unique B cell response to spirochetes,
or alternatively, the response is triggered by an antigen(s) not
present on the culture-grown bacteria used for immunization.
Since neither the lymphadenopathy nor the B cell response were
significantly different following infection of MyD882/2 mice
compared to controls (Figure 7), TLR-mediated inflammatory
responses can be excluded as potential triggers of this response, in
contrast to apparently similar TLR-4-mediated alterations follow-
ing S. typhimurium infection [17].
From this, it is tempting to speculate that it is the expression of
specific immune-subversion antigens by B. burgdorferi in the
mammalian host that induce overshooting and potentially
aberrant T cell independent B cell responses that are neither of
sufficient high-affinity nor induce memory responses able to
combat primary and repeat infections. The analysis of candidate
Figure 7. Lymphadenopathy and lymph node B cell activation are independent of MyD88-signaling. Control C57BL/6 (wildtype) and
congenic MyD882/2 mice (n=6 per group) were infected with host-adapted B. burgdorferi for 10 days. Lymph nodes were harvested and compared
for (A) total cellularity and (B) numbers of CD4, CD8 and CD19 as assessed by flow cytometry. ELISPOT analysis was conducted to determine numbers
of (C) borrelia-specific IgM or (D) all Ig-isotype secreting borrelia-specific cells. For scatter plots, each symbol represents the result from an individual
animal. Lines indicate mean of the group. Bar chart shows the mean values 6 SD. Results are pooled from two independent experiments. Statistical
analysis for (A) (C) (D) was conducted by Student’s t test and (B) by two-way ANOVA. None of the data showed significant differences between
control and MyD882/2 mice.
doi:10.1371/journal.ppat.1002066.g007
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comprehensively compare protein expression by culture-grown
and tissue-adapted spirochetes within the context of specific tissue
sites, such as lymph nodes.
While the induced B cell response to B. burgdorferi is unable to
clear the infection, it does provide immune protection from overt
disease. This is indicated by studies in B cell- or CD40L-deficient
mice that showed increased signs of tissue-inflammation and
disease progression compared to controls [29,40,45]. Furthermore,
passive transfer of immune serum from infected mice confers
immune protection from infection when injected prior to pathogen
challenge [26,30]. Thus, understanding the mechanisms that
induce and regulate the borrelia-specific B cell response is of
importance. Assessing the specificity of the B cell response to B.
burgdorferi is challenging, however, due to differences in the
antigenic structure of B. burgdorferi cultured in artificial media
versus those grown in the mammalian host [39,46–50]. Thus,
lysates or extracts from culture-grown spirochetes do not reflect
antigens expressed in the mammalian host. Furthermore, B.
burgdorferi differentially expresses antigens during the various stages
of its life cycle in the flat tick, the feeding tick and the host [39] .
We therefore utilized an infection protocol that mimics tick-borne
infection and avoids induction of immune responses to Borrelia
antigens not expressed in vivo, by infecting mice with mammalian
host-adapted spirochetes via tissue transplant.
For detection of B. burgdorferi-specific antibodies by ELISA and
ELISPOT, we used a cocktail of recombinant antigens, including
OspC, DbpA, Arp and BmpA, each of which are expressed during
infection of the mammalian host [36,47,49,51–53]. Furthermore,
each of these antigens have been shown to induce protective or
disease-resolving immune responses in mice [41,47,54–57]. We
did not include the VlsE protein in our studies, a surface-protein
thought to subvert the immune response to B. burgdorferi through
extensive genetic variation within the host. However, the N40
strain of B. burgdorferi, which we have used here, does not seem to
express this protein, based on transcriptional analysis of the IR6
region of vlsE. Moreover, we found no evidence of seroconversion
to the C6 antigen of vlsE from strain B31 (S. W. Barthold,
unpublished). Recent sequence analysis of the N40 genome has
confirmed that N40 vlsE and BBK01 are on different plasmids and
that the vlsE locus is indeed significantly different compared to
B31, the commonly used VlsE-expressing Borrelia-strain.
Using only a handful of such in vivo-expressed and immuno-
dominant antigens, we demonstrated the induction of a strong B.
burgdorferi-specific antibody response in the lymph nodes of infected
mice (Figures 5, 6) in a manner that is independent of MyD88
(Figure 7). We furthermore showed that nearly a quarter of
hybridomas generated from lymph nodes of acutely B. burgdorferi-
infected mice are specific for this pathogen (Figure 6). Together
with earlier studies that demonstrated the protective and disease-
resolving capacity of immune sera from long-term infected mice
[26,30,58], we can conclude that a strong and borrelia-specific B
cell response is induced in these lymph nodes.
B. burgdorferi causes spirochetemia, but its primary means of
dissemination is via migration through host connective tissues and
extracellular matrix [59] . This is consistent with our finding of
progressive involvement of the ipsilateral, but not the matching
contralateral lymph nodes of the host (Table 1). Furthermore, the
spleens of infected mice did not differ in size or in frequencies of B.
burgdorferi-specific antibody-secreting cells compared to spleens
from uninfected mice, and were only sporadically culture-positive
for spirochetes (Table 1). In apparent contrast, a previous study in
mice reported the involvement of marginal zone B cells in the
response to B. burgdorferi infection [60]. This difference to our study
might well be due to the difference in the route of infection, i.e.
intra-cutaneously with culture-grown bacteria at the back of
mouse versus infection with host-adapted spirochetes by tissue-
transplantation in the tarsus region. It has been well documented
that the course of infection and organ involvement varies with the
site of inoculation in mice [61,62]. Furthermore, it is notable that
tick-borne infections also failed to induce a significant B cell
response in the spleen (data not shown).
In conclusion, by accumulating in the extracellular cortical
spaces of the lymph node, B. burgdorferi seems to both induce and
subvert an important arm of the adaptive immune response.
Rather than fully suppressing the activity of B cells, B. burgdorferi
appears to shift the major B cell response towards the production
of antibodies generated in extrafollicular foci. It thereby seems to
support the production of antibodies that provide immune
protection from disease, while subverting the induction of more
strongly protective, possibly T-dependent B cell responses that
could confer bacterial clearance.
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